Skip to main content

Table 1 Characteristics of included GDFTdyn studies

From: The effects of goal-directed fluid therapy based on dynamic parameters on post-surgical outcome: a meta-analysis of randomized controlled trials

Study

Type of surgery

Risk

Number of participants*

Timing

GDFTdyn end point

Other optimization goals

Type of intervention

Mortality reported

Morbidity reported

Benes, 2010 [38] Europe

Major abdominal

High

120 (60/60)

Intra

SVV <10%

CI >2.5 l/min/m2, MAP >65 mmHg, CVP <15 mmHg,

Fluids, inotropes

Y

CV, GI, infectious, renal, respiratory

Buettner, 2008 [11] Europe

Major abdominal

Moderate

80 (40/40)

Intra

SPV <10%

N/A

Fluids

Y

-

Forget, 2010 [37] Europe

Abdominal

Moderate

82 (41/41)

Intra

PVI <10%

MAP >65 mmHg

Fluids

Y

CV, GI, infectious, renal

Goepfert, 2013 [36] Europe

Elective cardiac

High

100 (50/50)

Intra, post

SVV <10%

CI >2.0 l/min/m2, MAP >65 mmHg, HR 50-100 bpm, EVLWI ≤12 ml/kg

Fluids, inotropes

N

CV, infectious, respiratory, renal

Harten, 2008 [35] Europe

Emergency abdominal

High

29 (15/14)

Intra

PPV <10%

N/A

Fluids

Y

CV, GI, infectious, renal, respiratory

Kapoor, 2008 [39] India

Cardiac

High

27 (14/13)

Intra, post

SVV <10%

CI >2.5 mL/min/m2, CVP >6 mmHg, ScvO2 > 70%, SVI >30 ml/m2, SVRI >1,500 dynes.s/cm5/m2, DO2I >450 mL/min/m2

Fluids, inotropes

Y

GI, CV, renal, respiratory

Lopes, 2007 [10] Brazil

Major abdominal

High

33 (16/17)

Intra

PPV <10%

N/A

Fluids

Y

CV, GI, infectious, renal, respiratory

Mayer, 2010 [40] Europe

Major abdominal

High

60 (30/30)

Intra

SVV <12%

CI >2.5 mL/min/m2, MAP >65 mmHg, SVI >35 ml/m2

Fluids, inotropes

Y

Renal, respiratory

Ramsingh, 2013 [34] USA

Major abdominal

High

38 (20/18)

Intra

SVV <13%

N/A

Fluids

N

-

Salzwedel, 2013 [30] Europe

Elective abdominal

Moderate

160 (81/79)

Intra

PPV <10%

CI >2.5 mL/min/m2, MAP >65 mmHg

Fluids, inotropes

N

CV, GI, infectious, renal, respiratory

Sheeren, 2013 [33] Europe

Major abdominal

High

52 (26/26)

Intra

SVV <10%

SV increase >10%

Fluids

Y

CV, GI, infectious, renal, respiratory

Zhang Ju, 2012 [32] China

Major abdominal

Low

60 (20/40)

Intra

PPV <11%

N/A

Fluids

N

CV, GI, infectious, renal, respiratory

Zhang Ji, 2013 [31] China

Thoracic

Moderate

60 (30/30)

Intra

SVV <9%

CI >2.5 mL/min/m2, MAP >65 mmHg

Fluids, inotropes

N

GI, infectious, renal, Respiratory

Zheng, 2013 [29] China

Elective abdominal

Moderate

60 (30/30)

Intra, post

SVV <12%

CI >2.5 mL/min/m2, MAP >65 mmHg, SVI >35 ml/m2

Fluids, inotropes

N

CV, GI

  1. *Number of participants displayed as overall (control/intervention); complications. GDFTdyn: goal-directed fluid therapy based on dynamic parameters; SVV: stroke volume variation; CV: cardiovascular; GI: abdominal (gastrointestinal/liver); MAP: mean arterial pressure; CVP: central venous pressure; SPV: systolic pressure variation; N/A, not available; PVI: pleth variability index; CI: cardiac index; HR, heart rate; EVLWI: extravascular lung water index; PPV: pulse pressure variation; SVI: stroke volume index; SVRI: systemic vascular resistance index; ScvO2: central venous oxygen saturation; DO2I: oxygen delivery index.